Medallion Wealth Advisors’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Other funds holding PRQR
6CM
KCM
LCM
Medallion Wealth Advisors's PRQR Position: Q3 2026 in Review
Medallion Wealth Advisors held its ProQR Therapeutics (PRQR) position steady in Q3 2026 at 10 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #1214.
Medallion Wealth Advisors first reported a position in PRQR in Q4 2024 and has held it in 8 quarters since. The position peaked at $27 in Q4 2024. 73 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.
- Medallion Wealth Advisors held 10 shares of ProQR Therapeutics worth $17 as of Q3 2026.
- Medallion Wealth Advisors left its ProQR Therapeutics share count unchanged in Q3 2026.
- ProQR Therapeutics made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q3 2026, its #1214 holding.
- Medallion Wealth Advisors first reported a position in ProQR Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Medallion Wealth Advisors's ProQR Therapeutics position peaked at $27 in Q4 2024.
- 73 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.
Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.